RecruitingNot ApplicableNCT05714449

OCT Eccentric Fixation and Amblyopia in Children

OCT Eccentric Fixation, Fixation Stability, and Amblyopia in Children


Sponsor

State University of New York College of Optometry

Enrollment

30 participants

Start Date

Jan 25, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

The objectives of this proposal are to characterize the relationship between OCT eccentric fixation (OCT-EF), fixation eye movement (FEM), macular sensitivity in children with amblyopia.


Eligibility

Min Age: 4 YearsMax Age: 16 Years

Inclusion Criteria7

  • children with best-corrected visual acuity (BCVA) of 20/40 (equivalent to 0.3 logMAR) or worse in the amblyopic eye (ranging from 20/40 to 20/400), and interocular difference of BCVA was at least two logMAR lines,
  • ocular causes of amblyopia that were identified as refractive(i.e., anisometropic, strabismus, or strabismic-anisometropic.
  • Anisometropia included interocular difference of spherical equivalent >=1D or interocular difference of astigmatism cylinder magnitude >=1D;
  • strabismus included those with deviation >=10PD or good alignment after prior strabismus surgery;
  • combined type included those who meet the criteria of both anisometropia and strabismus.
  • For the patching group, we will enroll 15 children with strabismic amblyopia who are prescribed patching treatment. Age: 4-12 years old.
  • For the foveation therapy group, we will enroll 15 children with strabismic amblyopia who are prescribed foveation therapies. Age: 8-16 years old.

Exclusion Criteria3

  • born before 32 weeks gestational age;
  • neurologic, developmental, or systemic illnesses known to be associated with ocular pathologies;
  • congenital or acquired macular pathology.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEeye patch

standard amblyopia treatment

DEVICEAfter-image and MIT trainer

Common clinical training for foveation


Locations(1)

SUNY College of Optometry

New York, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05714449


Related Trials